Metro (MRU) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
4 Mar, 2026Executive summary
Total sales for the quarter reached CAD 6.65 billion, up 3.5% year-over-year, with food same-store sales up 2.4% and pharmacy up 5.2%.
Adjusted net earnings were CAD 305 million, down 3.1% from last year, with adjusted EPS flat at CAD 1.35; net earnings were CAD 296.2 million, down 14.6%, and fully diluted EPS was CAD 1.31, down 12.1%.
Gross margin was stable at 19.6% of sales, while operating expenses increased to 10.2% of sales due to new distribution center costs and higher e-commerce fees.
Market share gains were achieved in both dollars and tonnage, driven by strong performance in discount banners and effective merchandising.
Transition to new automated distribution centers in Terrebonne and Toronto completed, with productivity ramping up as planned.
Financial highlights
EBITDA was CAD 620.2 million, up 1.6% year-over-year, excluding asset sales impacts; operating income before depreciation, amortization, and impairments was $620.2 million (9.3% of sales), up 1.3%.
Depreciation and amortization rose to CAD 174 million, mainly from new distribution center investments.
Net financial costs increased to CAD 46.6 million due to higher debt and interest rates.
Online sales grew 35% year-over-year, supported by third-party delivery and expanded click-and-collect services.
Effective tax rate for the quarter was 25.9%, up from 16.6% last year due to a prior-year favorable tax adjustment.
Outlook and guidance
Results are tracking well to fiscal 2024 guidance, with expectations to return to usual profit growth targets in fiscal 2025 as distribution center transitions complete.
Operating income before depreciation and amortization and impairments expected to grow by less than 2% for Fiscal 2024.
Adjusted net earnings per share forecasted to be flat to down $0.10 for Fiscal 2024 versus Fiscal 2023.
Medium- and long-term annual net earnings per share growth target maintained at 8% to 10%.
Food inflation is decelerating, and cost pressures are expected to ease as automation ramps up.
Latest events from Metro
- Q2 sales up 5.5%, adjusted EPS up 12.1%, net earnings up 17.6%, supply chain investments ongoing.MRU
Q2 20254 Mar 2026 - Sales up 2.9%, adjusted EPS up 7.8%, online sales up 18.6%, and dividend raised 10.4%.MRU
Q1 20254 Mar 2026 - Q4 saw higher margins, strong pharmacy and online sales growth, and a completed supply chain overhaul.MRU
Q4 20244 Mar 2026 - Q3 sales rose 3.3%, adjusted EPS up 12.6%, with strong pharmacy and discount banner growth.MRU
Q3 20254 Mar 2026 - Q4 sales and earnings rose despite supply chain disruptions, with a strong FY 2026 outlook.MRU
Q4 20254 Mar 2026 - Sales up 3.3%, adjusted EPS up 5.5%, net earnings down 12.8% on one-time costs; dividend up 10.1%.MRU
Q1 20264 Mar 2026 - Strong results, board re-elections, and strategic growth plans highlighted, with rising dividends.MRU
AGM 20259 Jan 2026